Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment
James R. Kintzing, Maria V. Filsinger Interrante, Jennifer R. Cochran
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 12, pp. 993-1008
Open Access | Times Cited: 173

Showing 1-25 of 173 citing articles:

Next generation matrix metalloproteinase inhibitors — Novel strategies bring new prospects
Maxim Levin, Yael Udi, Inna Solomonov, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2017) Vol. 1864, Iss. 11, pp. 1927-1939
Closed Access | Times Cited: 169
Protein‐based Nanoparticles: From Drug Delivery to Imaging, Nanocatalysis and Protein Therapy
Jonas Kaltbeitzel, Peter Wich
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 44
Open Access | Times Cited: 41
Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics
Alessandro Zorzi, Sara Linciano, Alessandro Angelini
MedChemComm (2019) Vol. 10, Iss. 7, pp. 1068-1081
Open Access | Times Cited: 128
A guide to maximizing the therapeutic potential of protein–polymer conjugates by rational design
Jeong Hoon Ko, Heather D. Maynard
Chemical Society Reviews (2018) Vol. 47, Iss. 24, pp. 8998-9014
Open Access | Times Cited: 111
Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications
Eiji Yuba
Journal of Materials Chemistry B (2020) Vol. 8, Iss. 6, pp. 1093-1107
Closed Access | Times Cited: 102
Tumor‐Specific Self‐Degradable Nanogels as Potential Carriers for Systemic Delivery of Anticancer Proteins
Qiuwen Zhu, Xiaojie Chen, Xiao Xu, et al.
Advanced Functional Materials (2018) Vol. 28, Iss. 17
Closed Access | Times Cited: 100
Metal-Organic Framework Nanoparticle-Based Biomineralization: A New Strategy toward Cancer Treatment
Chengchao Chu, Min Su, Jing Zhu, et al.
Theranostics (2019) Vol. 9, Iss. 11, pp. 3134-3149
Open Access | Times Cited: 99
Nanosized Delivery Systems for Therapeutic Proteins: Clinically Validated Technologies and Advanced Development Strategies
Filippo Moncalvo, Maria Isabel Martinez Espinoza, Francesco Cellesi
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 86
Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
Ai‐Ming Yu, Mei‐Juan Tu
Pharmacology & Therapeutics (2021) Vol. 230, pp. 107967-107967
Open Access | Times Cited: 64
Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment
Jiewen Wang, Guangbo Kang, Haibin Yuan, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 53
Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging
Mengping Liu, Lin Wang, Young S. Lo, et al.
Cells (2022) Vol. 11, Iss. 1, pp. 159-159
Open Access | Times Cited: 50
Extracellular vesicles as an emerging drug delivery system for cancer treatment: Current strategies and recent advances
Zhenggang Wang, Haokun Mo, He Zhiyi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113480-113480
Open Access | Times Cited: 47
De novo design of immunoglobulin-like domains
Tamuka M. Chidyausiku, Soraia R. Mendes, Jason C. Klima, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Development and Recent Advances in Lysine and N-Terminal Bioconjugation for Peptides and Proteins
Ajcharapan Tantipanjaporn, Man‐Kin Wong
Molecules (2023) Vol. 28, Iss. 3, pp. 1083-1083
Open Access | Times Cited: 25
Electrically responsive release of proteins from conducting polymer hydrogels
Ernest Cheah, Mahima Bansal, Linh Nguyen, et al.
Acta Biomaterialia (2023) Vol. 158, pp. 87-100
Open Access | Times Cited: 22
Intracellular Delivery of Functional Proteins with DNA–Protein Nanogels–Lipids Complex
Marina Mariconti, Laurie Dechamboux, Marion Heckmann, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 8, pp. 5118-5127
Open Access | Times Cited: 10
Treating liver cancer through arginine depletion
Yenisetti Rajendra Prasad, J. Anakha, Abhay H. Pande
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103940-103940
Closed Access | Times Cited: 9
Therapeutic proteins: developments, progress, challenges, and future perspectives
Vimal Kumar, Arti Barwal, Nitin Sharma, et al.
3 Biotech (2024) Vol. 14, Iss. 4
Closed Access | Times Cited: 8
Polymersomes for Therapeutic Protein and Peptide Delivery: Towards Better Loading Properties
Chengxu Hua, Liyan Qiu
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2317-2340
Open Access | Times Cited: 6
Structure of theThomasclavelia ramosaimmunoglobulin A protease reveals a modular and minimizable architecture distinct from other immunoglobulin A proteases
Norman Tran, Aaron P. Frenette, Todd Holyoak
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Engineered Immunomodulatory Extracellular Vesicles from Epithelial Cells with the Capacity for Stimulation of Innate and Adaptive Immunity in Cancer and Autoimmunity
Xin Luo, Fernanda G. Kugeratski, Dara P. Dowlatshahi, et al.
ACS Nano (2025)
Closed Access
PASylation®: A versatile technology to extend drug delivery
Uli Binder, Arne Skerra
Current Opinion in Colloid & Interface Science (2017) Vol. 31, pp. 10-17
Closed Access | Times Cited: 80
Cyclotides: Overview and Biotechnological Applications
Andrew Gould, Julio A. Camarero
ChemBioChem (2017) Vol. 18, Iss. 14, pp. 1350-1363
Open Access | Times Cited: 66
Cell-surface proteomics for the identification of novel therapeutic targets in cancer
Laura Kuhlmann, Emma Cummins, Ismael Samudio, et al.
Expert Review of Proteomics (2018) Vol. 15, Iss. 3, pp. 259-275
Closed Access | Times Cited: 62
Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma
Jun W. Kim, César Márquez, Kaja Kostyrko, et al.
Nature Medicine (2019) Vol. 25, Iss. 11, pp. 1783-1795
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top